Canada
LocationRelationship Network
Event Timeline
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
location
United States
|
International relations |
7
|
1 | |
|
location
China
|
Geopolitical diplomatic |
5
|
1 | |
|
location
United States
|
Strategic ally |
5
|
1 | |
|
location
India
|
International cooperation |
5
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| N/A | N/A | Expected enactment of recreational cannabis law in Canada | Canada | View |
| N/A | N/A | Anticipated enactment and implementation of Canada's recreational Cannabis Act | Canada | View |
| N/A | N/A | Expected legalization of recreational cannabis in Canada | Canada | View |
| N/A | N/A | India's development of a nuclear bomb | India | View |
| 1988-11-17 | N/A | Signing of Extradition Treaty between France and Canada. | Ottawa | View |
HOUSE_OVERSIGHT_024887.jpg
This document is page 71 of a 'Cowen Collaborative Insights' market research report dated February 25, 2019. The text focuses on the textile industry, specifically analyzing the use of hemp by brands like Patagonia and Nike, and the emerging technology of infusing fabrics with CBD or recovery minerals like Celliant (used by Under Armour). While the document bears a 'HOUSE_OVERSIGHT' Bates stamp, the content itself contains no direct mentions of Jeffrey Epstein, criminal activity, or flight logs; it appears to be part of a larger subpoenaed document cache related to financial or corporate records.
HOUSE_OVERSIGHT_024886.jpg
This document is page 70 of a Cowen market research report dated February 25, 2019, titled 'Collaborative Insights.' It analyzes the growing market for hemp and CBD in the apparel and footwear industries, citing data on the 2014 and 2018 Farm Bills and listing brands like Patagonia and prAna. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp (indicating it was part of a congressional document production, likely related to financial investigations), the text itself contains no direct references to Jeffrey Epstein, Ghislaine Maxwell, or their specific associates.
HOUSE_OVERSIGHT_024875.jpg
This document is page 59 of a Cowen Collaborative Insights financial report dated February 25, 2019, analyzing the Cannabis/CBD market. It presents comparative financial data (Revenue, Gross Profit, and Gross Margin) for several companies including Charlotte's Web, CV Sciences, and Level Brands. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional investigation document production.
HOUSE_OVERSIGHT_024874.jpg
This document is page 58 of a Cowen Collaborative Insights financial report dated February 25, 2019, analyzing the cannabis and CBD industry. It details strategic updates, retail distribution benchmarking (store counts), and revenue figures for companies including TGOD, HEXO, Neptune, Organigram, Charlotte's Web, and Tilray. While the content is strictly financial analysis, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024874', indicating it was part of a document production for a US House Oversight Committee investigation, likely related to broader financial inquiries.
HOUSE_OVERSIGHT_024873.jpg
This document is page 57 of a Cowen Collaborative Insights report dated February 25, 2019, detailing the strategies of major Canadian cannabis companies (Aphria, Aurora, Canopy Growth, Cronos, Emblem, and Emerald Health) regarding the hemp and CBD markets. It aggregates quotes from CEO earnings calls and press releases concerning market expansion into Europe and the US, as well as strategic partnerships. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was likely part of a document production for a congressional investigation.
HOUSE_OVERSIGHT_024872.jpg
This document is a page from a Cowen Collaborative Insights equity research report dated February 25, 2019. It analyzes several companies in the cannabis and tobacco sectors, including GTI, Khiron Life Sciences, Level Brands, Tilray, and Turning Point Brands, providing revenue figures, stock ratings, and acquisition details. The document bears a House Oversight Committee Bates stamp, suggesting it was included in document production for a congressional investigation, likely related to financial institutions, though the page itself contains no direct references to Jeffrey Epstein.
HOUSE_OVERSIGHT_024837.jpg
This document is page 21 of a Cowen Collaborative Insights report dated February 25, 2019, analyzing a strategic partnership between Cronos Group and Ginkgo Bioworks valued at $122MM. The text details the financial structure of the deal, including R&D funding and equity milestones for producing specific cannabinoids like THC and CBD. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, likely included in a larger cache of internal financial documents.
HOUSE_OVERSIGHT_024822.jpg
This document is the Table of Contents for a 'Cowen Collaborative Insights' research report dated February 25, 2019, focusing on the CBD and Cannabis market. The report covers various sectors including consumer products, healthcare, and global landscapes, with sections attributed to specific analysts (e.g., Azer, Nadeau, Schenkel). The document bears a 'HOUSE_OVERSIGHT_024822' Bates stamp, indicating it is part of a document production to the House Oversight Committee, likely related to investigations into financial records.
HOUSE_OVERSIGHT_024821.jpg
This Cowen report page discusses the global regulatory landscape for CBD, highlighting developments in Europe and Latin America, and analyzes the U.S. regulatory outlook following the 2018 Farm Bill. It details the shifting oversight from the DEA to the Department of Agriculture while noting continued FDA authority and regulatory uncertainty regarding CBD products.
HOUSE_OVERSIGHT_024813.jpg
This document is a 2018 market landscape infographic titled 'The Green Field 2018' produced by Ackrell Capital. It categorizes dozens of companies within the cannabis industry into sectors including Cultivation, Production Equipment, Testing Services, Dispensaries, E-Commerce, and Distribution Services. The document bears a Bates stamp 'HOUSE_OVERSIGHT_024813', indicating it is part of a document production for the House Oversight Committee, likely related to broader investigations involving financial networks or specific individuals (contextually linked to Epstein investigations via the prompt, though Epstein is not named in this specific image).
HOUSE_OVERSIGHT_024806.jpg
This document is page 170 of a 'Cannabis Investment Report' published by Ackrell Capital, LLC in December 2017. It consists of a glossary defining various terms related to the cannabis industry, including scientific terms (Cannabinoid, CBN), legal frameworks (Cole Memo, CSA, CDSA), and international treaties. The page bears a 'HOUSE_OVERSIGHT_024806' bates stamp, indicating it was part of a document production to the House Oversight Committee.
HOUSE_OVERSIGHT_024805.jpg
This document is page 169 (Chapter X) of a report produced by Ackrell Capital, LLC, dated 2017. It serves as a 'Glossary of Terms' specifically related to the cannabis industry, defining terms such as ACMPR, Aeroponics, BHO, Bong, BSA (Bank Secrecy Act), and various cannabinoids (CBC, CBD, CBDA, CBG, CBGA). The document bears the Bates stamp 'HOUSE_OVERSIGHT_024805', indicating it was part of a document production to the House Oversight Committee.
HOUSE_OVERSIGHT_024796.jpg
This document is page 160 of a Cannabis Investment Report dated December 2017, authored by Ackrell Capital. It profiles four companies: Strainz, Teewinot Life Sciences, Tikun Olam, and Treez, providing their locations, websites, and brief business descriptions. The document bears the Bates stamp HOUSE_OVERSIGHT_024796, indicating it was part of a document production for a House Oversight Committee investigation.
HOUSE_OVERSIGHT_024787.jpg
This document is page 151 of a report titled 'Top 100 Private Cannabis Companies 2018' produced by Ackrell Capital. It profiles four companies: Humboldt Legends, Incense Specialties, Jetty Extracts, and Kikoko, providing their locations, websites, and brief business descriptions. The document bears a 'HOUSE_OVERSIGHT_024787' stamp, indicating it was part of a document production for a House Oversight Committee investigation.
HOUSE_OVERSIGHT_024775.jpg
This document is page 139 of an Ackrell Capital investment report titled 'Chapter VIII Top 100 Private Cannabis Companies 2018'. It provides company profiles for AEssenseGrows, Ample Organics, Apeks Supercritical, and The Apothecarium, detailing their locations, websites, and business descriptions. The document bears the Bates stamp HOUSE_OVERSIGHT_024775, indicating it was part of a document production to the House Oversight Committee.
HOUSE_OVERSIGHT_024768.jpg
This document is page 132 of a December 2017 Cannabis Investment Report by Ackrell Capital, LLC. It provides a detailed comparison of Canadian stock markets (TSX, TSXV, and CSE) regarding their suitability for cannabis-related companies, listing requirements, and market values. The document bears a 'HOUSE_OVERSIGHT_024768' Bates stamp, indicating it was part of a document production to the House Oversight Committee, though no specific individuals (Epstein or otherwise) are named in the text of this specific page.
HOUSE_OVERSIGHT_024767.jpg
This document is page 131 of a report by Ackrell Capital titled 'Chapter VII Capital Markets for Cannabis Companies.' It presents a detailed financial table of companies listed on the Canadian Securities Exchange as of November 30, 2017. The table includes stock prices, market values, enterprise values, revenue, and EBITDA multiples for numerous cannabis-related entities. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024767', indicating it was part of a production to the House Oversight Committee.
HOUSE_OVERSIGHT_024765.jpg
This document is page 129 of a financial report by Ackrell Capital, LLC, titled 'Chapter VII Capital Markets for Cannabis Companies'. It presents a bar chart and table analyzing capital raised by Canadian publicly traded cannabis companies for the Last Twelve Months (LTM) ended September 30, 2017, sourced from S&P Global Market Intelligence. While part of a House Oversight document dump (indicated by Bates stamp HOUSE_OVERSIGHT_024765), the page contains purely financial market metrics regarding the TSX, TSXV, and CSE exchanges and names no specific individuals.
HOUSE_OVERSIGHT_024764.jpg
This document is page 128 of a December 2017 Cannabis Investment Report by Ackrell Capital. It features a line graph tracking Canadian Cannabis Stock Price Performance against various indices from September 2016 to November 2017, highlighting market events such as the PM's legalization announcement and Constellation Brands' investment in Canopy Growth. The page bears the Bates stamp HOUSE_OVERSIGHT_024764, indicating it is part of a larger production of documents, likely related to congressional oversight, though no specific connection to Jeffrey Epstein or his associates is visible in the text of this specific page.
HOUSE_OVERSIGHT_024763.jpg
This document is page 127 of a report by Ackrell Capital titled 'Capital Markets for Cannabis Companies.' It provides a financial summary of Canadian publicly traded cannabis-related companies as of November 30, 2017, including market value and revenue data for companies on the TSX, TSXV, and CSE. The text also references the positive market impact of Prime Minister Justin Trudeau's legislative announcements and an investment by Constellation Brands into Canopy Growth. The document bears a 'HOUSE_OVERSIGHT' Bates stamp.
HOUSE_OVERSIGHT_024757.jpg
This page from an Ackrell Capital report details capital raised by publicly traded cannabis companies for the year ending September 30, 2017, highlighting that Canadian companies raised significantly more capital than those in the U.S. or Australia. It also provides an overview of the U.S. public capital markets for cannabis, noting that while a few trade on major exchanges like Nasdaq and NYSE, the vast majority are "penny" stocks on the OTC market characterized by high risk and regulatory scrutiny from the SEC and FINRA.
HOUSE_OVERSIGHT_024756.jpg
This document is page 120 of a December 2017 Cannabis Investment Report by Ackrell Capital. It analyzes the stock price performance and capital raising activities of cannabis-related companies in the U.S., Canada, and Australia, noting resilience despite U.S. political changes (Trump/Sessions) and growth driven by Canadian legislation and strategic investments. The document bears a 'HOUSE_OVERSIGHT' stamp, but contains no direct mentions of Jeffrey Epstein or his known associates on this specific page.
HOUSE_OVERSIGHT_024755.jpg
This document is page 119 of a report by Ackrell Capital titled 'Capital Markets for Cannabis Companies.' It analyzes listing requirements for cannabis companies on US, Canadian, and Australian stock exchanges (NYSE, Nasdaq, OTC, TSX, CSE, ASX). It includes a statistical table summarizing market values, enterprise values, and revenue averages for cannabis-related companies as of November 30, 2017. The document bears a House Oversight Committee stamp.
HOUSE_OVERSIGHT_024754.jpg
This document is page 118 of a Cannabis Investment Report authored by Ackrell Capital in December 2017. It analyzes public capital markets, detailing strategic investments by major corporations like Constellation Brands and Scotts Miracle-Gro into the cannabis sector, and discusses market valuations and regulatory landscapes in the US, Canada, and abroad. The document bears a House Oversight stamp (024754), indicating it was likely gathered as evidence in a congressional investigation, though Jeffrey Epstein is not mentioned on this specific page.
HOUSE_OVERSIGHT_024750.jpg
This document is page 114 from an Ackrell Capital 'Cannabis Investment Report' dated December 2017. It presents a data table titled 'Emerging and Anticipated International Legal Cannabis Markets,' detailing GDP rank, population, projected spending, and potential market value for various countries. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024750,' indicating it was part of a document production to the House Oversight Committee, likely related to investigations into financial institutions connected to Epstein, though the content itself is strictly market analysis.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity